Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
3.870
+0.020 (0.52%)
May 9, 2025, 11:20 AM - Market open

Company Description

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.

It also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic data from microarray and next-generation sequencing data for cytogenetics and molecular genetics.

In addition, the company offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing.

Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Bionano Genomics, Inc.
Bionano Genomics logo
Country United States
Founded 2003
IPO Date Aug 21, 2018
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 100
CEO Robert Holmlin

Contact Details

Address:
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
United States
Phone 858 888 7600
Website bionano.com

Stock Details

Ticker Symbol BNGO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001411690
CUSIP Number 09075F107
ISIN Number US09075F3055
Employer ID 26-1756290
SIC Code 3826

Key Executives

Name Position
Dr. Robert Erik Holmlin M.B.A., Ph.D. President, Chief Executive Officer, Chief Financial Officer and Director
Mark Oldakowski Chief Operating Officer
Dr. Alka Chaubey FACMG, Ph.D. Chief Medical Officer
Jonathan Dixon J.D. General Counsel and Secretary
Stanislas Marin M.B.A., M.S. Vice President of Global Sales
Donna Polizio Global Head of Market Access
Cory Kreeck Global Head of People Operations

Latest SEC Filings

Date Type Title
Apr 28, 2025 ARS Filing
Apr 28, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 28, 2025 DEF 14A Other definitive proxy statements
Apr 18, 2025 PRE 14A Other preliminary proxy statements
Apr 2, 2025 424B5 Filing
Apr 2, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 31, 2025 10-K Annual Report
Mar 31, 2025 8-K Current Report
Feb 21, 2025 8-K Current Report
Feb 21, 2025 424B5 Filing